The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies. [electronic resource]
Producer: 20171120Description: 53-60 p. digitalISSN:- 1532-1967
- Animals
- Breast Neoplasms -- drug therapy
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Female
- Humans
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- therapeutic use
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.